Literature DB >> 12710940

Role of homologous recombination in carcinogenesis.

Alexander J R Bishop1, Robert H Schiestl.   

Abstract

Cancer develops when cells no longer follow their normal pattern of controlled growth. In the absence or disregard of such regulation, resulting from changes in their genetic makeup, these errant cells acquire a growth advantage, expanding into precancerous clones. Over the past decade many studies have revealed the relevance of genomic mutation in this process, be it by misreplication, environmental damage, or a deficiency in repairing endogenous and exogenous damage. Here we discuss the possibility of homologous recombination as an errant DNA repair mechanism that can result in loss of heterozygosity or genetic rearrangements. Some of these genetic alterations may play a primary role in carcinogenesis, but they are more likely to be involved in secondary and subsequent steps of carcinogenesis by which recessive oncogenic mutations are revealed. Patients, whose cells display an increased frequency of recombination, also have an elevated frequency of cancer, further supporting the link between recombination and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710940     DOI: 10.1016/s0014-4800(03)00010-8

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  22 in total

1.  Role of the Exocyst Complex Component Sec6/8 in Genomic Stability.

Authors:  Michael J Torres; Raj K Pandita; Ozlem Kulak; Rakesh Kumar; Etienne Formstecher; Nobuo Horikoshi; Kalpana Mujoo; Clayton R Hunt; Yingming Zhao; Lawrence Lum; Aubhishek Zaman; Charles Yeaman; Michael A White; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

2.  Repetitive sequences, genomic instability and Barrett's esophageal adenocarcinoma.

Authors:  Masood A Shammas
Journal:  Mob Genet Elements       Date:  2011-09-01

3.  Age-dependent accumulation of recombinant cells in the mouse pancreas revealed by in situ fluorescence imaging.

Authors:  Dominika M Wiktor-Brown; Carrie A Hendricks; Werner Olipitz; Bevin P Engelward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

4.  Genotoxic evaluation of bupivacaine and levobupivacaine in the Drosophila wing spot test.

Authors:  Mehmet Gürbüzel; Ugur Karaca; Nermin Karayilan
Journal:  Cytotechnology       Date:  2015-02-19       Impact factor: 2.058

Review 5.  Can corruption of chromosome cohesion create a conduit to cancer?

Authors:  Huiling Xu; Jonathan M Tomaszewski; Michael J McKay
Journal:  Nat Rev Cancer       Date:  2011-02-17       Impact factor: 60.716

6.  Integrated one- and two-photon imaging platform reveals clonal expansion as a major driver of mutation load.

Authors:  Dominika M Wiktor-Brown; Hyuk-Sang Kwon; Yoon Sung Nam; Peter T C So; Bevin P Engelward
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-22       Impact factor: 11.205

7.  DNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genes.

Authors:  Cynthia L Innes; Jill E Hesse; Abigail J Morales; Beth A Helmink; Shepherd H Schurman; Barry P Sleckman; Richard S Paules
Journal:  Cell Cycle       Date:  2019-11-22       Impact factor: 4.534

Review 8.  Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.

Authors:  Manny D Bacolod; Gunter S Schemmann; Sarah F Giardina; Philip Paty; Daniel A Notterman; Francis Barany
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

9.  Alteration of genetic recombination and double-strand break repair in human cells by progerin expression.

Authors:  Celina J Komari; Anne O Guttman; Shelby R Carr; Taylor L Trachtenberg; Elise A Orloff; Ashley V Haas; Andrew R Patrick; Sona Chowdhary; Barbara C Waldman; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2020-09-28

Review 10.  Novel aspects of macromolecular repair and relationship to human disease.

Authors:  Hans E Krokan; Bodil Kavli; Geir Slupphaug
Journal:  J Mol Med (Berl)       Date:  2004-02-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.